Related Experiment Videos
A Case of Statin-Induced Fulminant Hepatitis Presenting as Septic Shock and Multiorgan Failure
Matthew E Lehrack1, John Daliva2, Nadir E Eltahir3
1Internal Medicine, Western University of Health Sciences, Pomona, USA.
Abstract:
Statins are among the most widely prescribed medications for hyperlipidemia, with drug-induced liver injury (DILI) being a rare adverse event. Here, we report a case involving a 69-year-old female patient who developed fulminant liver failure following an overdose of rosuvastatin. The patient had ingested 60 tablets of rosuvastatin 20 mg over the one-week period prior to hospital admission, mistakenly believing it was her pain medication. This acute high-dose exposure far exceeded recommended dosing and resulted in fulminant hepatitis and multiorgan failure. Despite comprehensive critical care, including advanced supportive and rescue interventions, the patient's condition deteriorated, and she did not survive. This underscores the potential lethality of statin overdose and the importance of medication safety, early recognition, and prevention strategies.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cirrhosis II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Cholecystitis
Rocky Mountain Spotted Fever
Cirrhosis I: Introduction